ASS1 and melanoma: Cisplatin is another cytotoxic agent shown preclinically to enhance the effects of ADI-PEG20 by inhibition of DNA repair [70] and ASS1 suppression by upregulation of HIF-1α and downregulation of c-Myc in melanoma cell lines [71].